Houston Area Translational Research Consortium Inc
Nonprofit profile at a glance
- EIN
- 455431287
- IRS 990 coverage
- 2012–2014
- Forms available
- Form 990 2014
- Location
- Houston, TX, USA
- Phone
- 7133486040
- Rating confidence
- Limited
- Sector
- Research Institutes and Public Policy Analysis
Reported finances
- Revenue
- $0
- Expenses
- $0
- Assets
- $0
- Liabilities
- $0
Source: IRS Form 990. Selected filing: tax year 2014. Amounts in USD.
Leadership & pay
6 people listed
Source: IRS Form 990. Selected filing: tax year 2014. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
The consortium will: (i) provide educational, consulting and networking opportunities for teachers, researchers, clinicians and students with the Texas medical center; (ii) facilitate collaborative relationships between innovators, biotechnology companies, and other experts in the life sciences field in order to support successful commercialization of technology for the prevention, treatment and cure of cancer and related diseases; and (iii) promote houston as a leader in life sciences research.
What it reported doing in 2014
The consortium will expedite the transition of scientific breakthroughs from the laboratory into life-saving products and technologies to aid in the fight against cancer and other diseases. The consortium will draw ideas, research, and talent from the Texas medical center and introduce new health sciences business and jobs to Texas, building houston into the next major hub of biotechnology and investment. The Texas medical center is adjacent to rice, and is a key partner with rice in biomedical research and development. Established in 1945, it is the world's largest medical complex with one of the highest densities of clinical facilities devoted to patient care, basic science and translational research. It contains 54 medicine-related institutions, including 13 hospitals and two institutions, two medical schools, four nursing schools and schools of dentistry, public health, pharmacy and other health-related practices. All 54 institutions are not-for-profit.
Operating model
- Revenue model
- No positive adjusted resources. The filing reports no positive adjusted operating resources.
- Distribution model
- No current program activity. The filing reports no program spending for the current year.
The verdict
- The available evidence is not sufficient to produce an overall rating for this filing. This is not a warning sign.
Rating breakdown
- Financial Efficiency: NotEnoughData
- Transparency & Controls: 52
- Accountability: 51
- Sustainability: NotEnoughData
- Growth: NotEnoughData
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: Limited
- Program expense ratio: Limited
- Fundraising efficiency: Limited
Transparency & Controls
- Consistency checks: 85.7%; rating input score 86; 3rd percentile among comparable filings
- Pay-setting controls: 0 of 6 controls in place; rating input score 0
- Compensation committee: Missing
- Independent consultant: Missing
- Other Form 990s reviewed: Missing
- Written employment contract: Missing
- Compensation survey or study: Missing
- Board or committee approval: Missing
- Foreign activity oversight: Limited
- Grant itemization coverage: Limited
- Major donor itemization: Limited
- Related-party transparency: Limited
Accountability
- Independent voting board: 25%; rating input score 25; 18th percentile among comparable filings
- Governance controls: 7 of 8 controls in place; rating input score 88
- Conflict-of-interest policy: Pass
- Whistleblower policy: Pass
- Document-retention policy: Pass
- CEO compensation review process: NotApplicable
- Other executive compensation review process: Pass
- Form 990 shared with the board: Pass
- Board meeting minutes documented: Pass
- Audit committee oversight: Fail
- Independent financial-statement audit: Pass
Sustainability
- Operating margin: Limited
- Total-asset coverage ratio: Limited
- Liabilities to assets ratio: Limited
- Officer compensation ratio: Limited
Growth
- Program expense growth: Limited
- Revenue growth: Limited
- Asset growth: Limited
Details
- Where the money goes: Financial trends and filed revenue, expense, asset, and liability detail
- Governance: 1 of 4 board members independent · 7 of 8 filing controls reported
- Programs: 1 filed program accomplishment
- Leadership: top reported pay $646K · 6 people listed · 0 of 6 pay-setting controls reported
- Consistency: 12 of 13 current checks pass · 1 finding to review
- Schedules: 4 filed schedules · includes executive pay
- Filing history: 3 filing years from 2012 to 2014
- Contacts: How to reach this organization
- Related organizations: 15 filed related-organization links
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Transparency & Controls: Pay-setting controls scored 0/100.
- High — Accountability: Independent voting board scored 25/100.
- Moderate — Transparency & Controls: Series filing activity did not reconcile in the filed values.
- Review — Accountability: Governance controls: Audit committee oversight not reported.